Vascular Targeting Agents as Cancer Therapeutics, Clinical Cancer Research, vol.10, issue.2, pp.415-427, 2004. ,
DOI : 10.1158/1078-0432.CCR-0642-03
Tumour vascular targeting, Nature Reviews Cancer, vol.74, issue.6, pp.436-446, 2005. ,
DOI : 10.1016/j.ab.2003.09.040
Tumour targeting by microtubule-depolymerising vascular disrupting agents, Expert Opinion on Therapeutic Targets, vol.6, issue.11, pp.1443-1457, 2007. ,
DOI : 10.1083/jcb.200303082
Targeting Tumour Vasculature as a Cancer Treatment, Computational and Mathematical Methods in Medicine, vol.8, issue.1, pp.1-9, 2007. ,
DOI : 10.1080/17486700701298319
Microtubule depolymerizing vascular disrupting agents: novel therapeutic agents for oncology and other pathologies, International Journal of Experimental Pathology, vol.92, issue.4 Suppl. 1, pp.284-294, 2009. ,
DOI : 10.1111/j.1365-2613.2009.00651.x
Anticancer strategies involving the vasculature, Nature Reviews Clinical Oncology, vol.68, issue.7, pp.395-404, 2009. ,
DOI : 10.1038/nrclinonc.2009.52
Vascular Disrupting Agents (VDAs) in Anticancer Therapy, Current Clinical Pharmacology, vol.5, issue.3, p.178, 2010. ,
DOI : 10.2174/157488410791498815
The biology of the combretastatins as tumour vascular targeting agents, International Journal of Experimental Pathology, vol.81, issue.Suppl. 1, pp.21-38, 2002. ,
DOI : 10.1046/j.1365-2613.2002.00211.x
Disrupting tumour blood vessels, Nature Reviews Cancer, vol.48, issue.8, pp.423-435, 2005. ,
DOI : 10.1038/sj.bjc.6690416
Tumor Angiogenesis, New England Journal of Medicine, vol.358, issue.19, pp.2039-2049, 2008. ,
DOI : 10.1056/NEJMra0706596
The unique characteristics of tumor vasculature and preclinical evidence for its selective disruption by Tumor-Vascular Disrupting Agents, Cancer Treatment Reviews, vol.37, issue.1, pp.63-74, 2011. ,
DOI : 10.1016/j.ctrv.2010.05.001
A perspective on vascular disrupting agents that interact with tubulin: preclinical tumor imaging and biological assessment, Integrative Biology, vol.8, issue.4, pp.375-387, 2011. ,
DOI : 10.1039/c0ib00135j
Isolation and structure of the strong cell growth and tubulin inhibitor combretastatin A-4, Experientia, vol.65, issue.2, pp.209-211, 1989. ,
DOI : 10.1007/BF01954881
In Vitro Metabolism Study of Combretastatin A-4 in Rat and Human Liver Microsomes, Drug Metabolism and Disposition, vol.35, issue.12, pp.2252-2261, 2007. ,
DOI : 10.1124/dmd.107.016998
Combretastatin A-4 Analogues as Antimitotic Antitumor Agents, Current Medicinal Chemistry, vol.10, issue.17, pp.1697-1722, 2003. ,
DOI : 10.2174/0929867033457151
Combretastatins: from natural products to drug discovery, Natural Product Reports, vol.20, issue.6, pp.558-564, 2003. ,
DOI : 10.1039/b306797c
Pharmaceutical Design of Antimitotic Agents Based on Combretastatins, Current Pharmaceutical Design, vol.11, issue.13, pp.1655-1677, 2005. ,
DOI : 10.2174/1381612053764751
Medicinal Chemistry of Combretastatin A4:?? Present and Future Directions, Journal of Medicinal Chemistry, vol.49, issue.11, pp.3033-3044, 2006. ,
DOI : 10.1021/jm0512903
Indole, a core nucleus for potent inhibitors of tubulin polymerization, Medicinal Research Reviews, vol.428, issue.2, pp.209-238, 2007. ,
DOI : 10.1002/med.20080
Developments of Combretastatin A-4 Derivatives as Anticancer Agents, Current Medicinal Chemistry, vol.18, issue.4, pp.523-538, 2011. ,
DOI : 10.2174/092986711794480221
Biological Potential and Structure-Activity Relationships of Most Recently Developed Vascular Disrupting Agents: An Overview of New Derivatives of Natural Combretastatin A-4, Current Medicinal Chemistry, vol.18, issue.20, pp.3035-3081, 2011. ,
DOI : 10.2174/092986711796391642
Syntheses and antitumor activity of cis-restricted combretastatins: 5-Membered heterocyclic analogues, Bioorganic & Medicinal Chemistry Letters, vol.8, issue.22, pp.3153-3158, 1998. ,
DOI : 10.1016/S0960-894X(98)00579-4
1,2,3-Triazole analogs of combretastatin A-4 as potential microtubule-binding agents, Bioorganic & Medicinal Chemistry, vol.18, issue.18, pp.6874-6885, 2010. ,
DOI : 10.1016/j.bmc.2010.07.032
Synthesis, biological evaluation and molecular modeling of 1,2,3-triazole analogs of combretastatin A-1, Bioorganic & Medicinal Chemistry, vol.20, issue.1, pp.234-242, 2012. ,
DOI : 10.1016/j.bmc.2011.11.010
Solution-Phase Parallel Synthesis and Biological Evaluation of Combretatriazoles, Journal of Combinatorial Chemistry, vol.10, issue.5, pp.732-740, 2008. ,
DOI : 10.1021/cc800090d
A versatile synthesis of 1-aryl-2-nitro-3-(3,4,5-trimethoxyphenyl)propenes as precursors of novel mescaline derivatives., CHEMICAL & PHARMACEUTICAL BULLETIN, vol.34, issue.4, pp.1628-1633, 1986. ,
DOI : 10.1248/cpb.34.1628
Insight into tubulin regulation from a complex with colchicine and a stathmin-like domain, Nature, vol.428, issue.6979, pp.198-202, 2004. ,
DOI : 10.1038/nature02393
The Tubulin Colchicine Domain: a Molecular Modeling Perspective, ChemMedChem, vol.23, issue.1, pp.33-42, 2012. ,
DOI : 10.1002/cmdc.201100361
Molecular recognition of receptor sites using a genetic algorithm with a description of desolvation, Journal of Molecular Biology, vol.245, issue.1, pp.43-53, 1995. ,
DOI : 10.1016/S0022-2836(95)80037-9
Isocombretastatins A: 1,1-Diarylethenes as potent inhibitors of tubulin polymerization and cytotoxic compounds, Bioorganic & Medicinal Chemistry, vol.17, issue.17, pp.6422-6431, 2009. ,
DOI : 10.1016/j.bmc.2009.07.012
Silica gel-assisted reduction of nitrostyrenes to 2-aryl-1-nitroalkanes with sodium borohydride, Tetrahedron Letters, vol.24, issue.3, pp.227-230, 1983. ,
DOI : 10.1016/S0040-4039(00)81371-4
Permanent cell line expressing human factor VIII-related antigen established by hybridization., Proceedings of the National Academy of Sciences, vol.80, issue.12, pp.3734-3737, 1983. ,
DOI : 10.1073/pnas.80.12.3734
URL : https://www.ncbi.nlm.nih.gov/pmc/articles/PMC394125/pdf
)CORINA ? Fast Generation of High-Quality 3D Molecular Models: http://www.molecular-networks.com/products/corina [63] Schrödinger Suite, Chem. Rev, vol.93, issue.1, p.2012, 1993. ,
Preclinical Antitumor Activity and Pharmacokinetics of Irinotecan (CPT-11) in Tumor-bearing Mice, Annals of the New York Academy of Sciences, vol.35, issue.1 The Camptothe, pp.173-180, 1996. ,
DOI : 10.1016/0378-4347(92)80156-K